全文获取类型
收费全文 | 8938篇 |
免费 | 542篇 |
国内免费 | 436篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 127篇 |
妇产科学 | 143篇 |
基础医学 | 382篇 |
口腔科学 | 22篇 |
临床医学 | 1517篇 |
内科学 | 1127篇 |
皮肤病学 | 41篇 |
神经病学 | 102篇 |
特种医学 | 173篇 |
外科学 | 3391篇 |
综合类 | 1119篇 |
预防医学 | 422篇 |
眼科学 | 30篇 |
药学 | 649篇 |
8篇 | |
中国医学 | 206篇 |
肿瘤学 | 455篇 |
出版年
2024年 | 76篇 |
2023年 | 179篇 |
2022年 | 281篇 |
2021年 | 429篇 |
2020年 | 350篇 |
2019年 | 291篇 |
2018年 | 283篇 |
2017年 | 289篇 |
2016年 | 327篇 |
2015年 | 416篇 |
2014年 | 645篇 |
2013年 | 665篇 |
2012年 | 515篇 |
2011年 | 472篇 |
2010年 | 423篇 |
2009年 | 397篇 |
2008年 | 427篇 |
2007年 | 436篇 |
2006年 | 375篇 |
2005年 | 383篇 |
2004年 | 321篇 |
2003年 | 248篇 |
2002年 | 200篇 |
2001年 | 208篇 |
2000年 | 153篇 |
1999年 | 118篇 |
1998年 | 76篇 |
1997年 | 76篇 |
1996年 | 80篇 |
1995年 | 106篇 |
1994年 | 77篇 |
1993年 | 72篇 |
1992年 | 65篇 |
1991年 | 44篇 |
1990年 | 39篇 |
1989年 | 44篇 |
1988年 | 51篇 |
1987年 | 26篇 |
1986年 | 44篇 |
1985年 | 44篇 |
1984年 | 32篇 |
1983年 | 19篇 |
1982年 | 24篇 |
1981年 | 15篇 |
1980年 | 18篇 |
1979年 | 15篇 |
1978年 | 11篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1973年 | 4篇 |
排序方式: 共有9916条查询结果,搜索用时 31 毫秒
891.
Naoki Igarashi Tetsuro Kubota Yoshihide Otani Shinjiro Wilson Matsuzaki Masahiko Watanabe Tatsuo Teramoto Koichiro Kumai Kazuhiko Tamaki Kazuhiko Tanzawa Tomowo Kobayashi Masaki Kitajima 《Cancer science》1999,90(1):116-121
R-94138, a matrix metalloproteinase inhibitor, was examined for the ability to prevent peritoneal dissemination of a human gastric cancer xenograft, TMK-1. When the supernatant of a co-culture of TMK-1 cells and human normal fibroblast cells was subjected to gelatin zymography, it was clear that the protein expression of MMP-2 had been inhibited by R-94138. When TMK-1 was injected intraperitoneally (i.p.) into nude mice at 5×105 cells/body, the resulting peritoneal dissemination mimicked clinical carcinomatous peritonitis. When the maximum tolerated dose of mitomycin C (MMC) or cisplatin (DDP) was given 12 h after the tumor inoculation, peritoneal dissemination was completely inhibited, while the effect of R-94138 was limited when it was given i.p. at a dose of 20 mg/kg in a schedule of q.d. ×5 starting 12 h after tumor injection. MMC and DDP also suppressed peritoneal dissemination when they were administered 1 week after the tumor inoculation at a single dose of 2 and 3 mg/kg i.p., respectively. R-94138 inhibited peritoneal dissemination when it was administered i.p. at a dose of 30 mg/kg in a schedule of q.d. ×5 starting from 1 week after tumor injection. The combination of MMC and R-94138 increased the preventive effect on peritoneal dissemination. R-94138 seems to be a promising candidate to prevent peritoneal dissemination of gastric cancer. 相似文献
892.
人胃癌细胞腹膜粘附影响因素的实验研究 总被引:5,自引:1,他引:5
目的 探讨影响人胃癌细胞在腹膜粘附的因素,为临床上采取有效措施,减少腹膜转移的发生提供依据。方法 用人胃癌细胞株在小鼠腹膜上培养,以MTT法检测粘附细胞数的体外实验模型,观察腹膜损伤,血液成分和癌胚抗原(CEA)对胃癌细胞在腹膜粘附的影响。结果 腹膜损伤组的粘附细胞数(AD)较对照组明显增高(P〈0.01),血液中的白细胞,血小板组AD值较对照组明显增高(P〈0.01),血浆组AD值亦较对照组增高 相似文献
893.
Sanket Mehta Lilian Schwarz John Spiliotis Mao-Chih Hsieh Eduardo H. Akaishi Diane Goere Paul H. Sugarbaker Dario Baratti François Quenet David L. Bartlett Laurent Villeneuve Vahan Kepenekian 《European journal of surgical oncology》2018,44(11):1786-1792
Introduction
Peritoneal metastasis (PM) of hepatocellular carcinoma (HCC) without distant spread are rare. The related prognosis is poor without standard treatment available. The role of cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly documented.Methods
An international multicentric cohort was constituted by retrospective analysis of 21 patients undergoing CRS/HIPEC for PM of HCC between 1992 and 2016 from 10 reference centers of PSOGI. Data on clinical features, treatment strategies, and survival outcomes were analyzed.Results
The median time interval from the diagnosis of PM to the procedure was 4.5 months. The median peritoneal cancer index was 14. Sixteen patients had complete cytoreduction (CCR0-1). Ten patients had grades 3 to 4 complications. The median duration of follow-up was 52.2 months. The median OS was 46.7 months. The projected 3y-OS and 5y-OS were 88.9 and 49.4% respectively. The median OS for patients with CCR0-1 resection was not reached whereas it was 5.9 months for those with CCR2-3 resection after CRS (p = 0.0005). The median RFS was 26.3 months and projected RFS at 3 years of 36.5 months Three prognostic factors were associated with improved RFS in the univariate analysis: preoperative chemotherapy (p = 0.0156), PCI >15 (p = 0.009), Number of chemotherapy agents used for HIPEC (p = 0.005).Conclusion
CRS/HIPEC is a safe and effective approach in selected patients with PM of HCC. CRS/HIPEC gives the patient a chance for a good relapse free and overall survival and should be considered as an option. 相似文献894.
Cristina Rihuete Caro Israel Manzanedo Fernando Pereira Lucía Carrion-Alvarez Ángel Serrano Estíbalitz Pérez-Viejo 《European journal of surgical oncology》2018,44(11):1805-1810
Background
Gastric Cancer (GC) with Peritoneal Carcinomatosis (PC) has long been regarded as a terminal disease. Over the past two decades, cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed the traditional concept of peritoneal metastases from being a systemic disease, to being considered a locoregional dissemination.Patients and methods
A prospective study was performed at a high-volume Carcinomatosis Center to evaluate survival, morbi-mortality and prognostic factors for survival in a cohort of patients with GC and PC treated with CRS + HIPEC between June 2006 and December 2016.Results
Thirty-five patients were included in the study. Median follow-up was 54 months. Postoperative major complications (>grade IIIa) occurred in 25.7% of patients, including 2 deaths (mortality 5.7%). The median overall survival (OS) was 16 months and the 1-, 3- and 5-year OS rates were 70.8%, 21.3% and 21.3% %, respectively. The median OS for patients with PCI ≤6 was 19 months, in contrast to 12 months for the 19 patients with PCI >6. Three patients were included with only a positive cytology and their median OS was not reached. Perineural invasion was the only factor that had a negative influence in prognosis (HR 18.8) in multivariate analysis.Conclusion
Although GC with PC still has a poor prognosis, survival has improved in selected patients with CRS + HIPEC and perioperative systemic chemotherapy. Patients with isolated positive cytology or peritoneal carcinomatosis with PCI less than 6 had encouraging survival rates. 相似文献895.
Charlotte E.L. Klaver Karin A.T.G.M. Wasmann Marlies Verstegen Jarmila D.W. van der Bilt Iris D. Nagtegaal Bert van Ramshorst Pieter J. Tanis Albert M. Wolthuis Hjalmar C. van Santvoort Johannes H.W. de Wilt André DHoore 《European journal of surgical oncology》2018,44(12)
Introduction
Patients with pT4 colon cancer are at risk of developing intra-abdominal recurrence. Infectious complications have shown to negatively influence disease free survival (DFS) and overall survival (OS) in stage I-III colon cancer. The aim of this study was to determine whether surgical site infections (SSIs) also increase the risk of intra-abdominal recurrence in pT4 colon cancer patients.Methods
All consecutive patients with pT4N0-2M0 colon cancer from four centres between January 2000 and December 2014 were included. Patients were categorized into 2 groups; with and without a postoperative (<30 days) SSIs. SSIs included both deep incisional as well as organ/space SSIs. The primary outcome was intra-abdominal recurrence (including local/incisional recurrence, peritoneal metastases) and was assessed using Kaplan-Meier and Cox regression analyses. Secondary outcome measures were DFS and OS.Results
Out of 420 patients, 62 (15%) developed a SSI. The 5-year intra-abdominal recurrence rates were 44% and 27% for patients with and without a SSI, respectively (p?=?0.011). After multivariate analysis, SSI was independently associated with intra-abdominal recurrence (HR 1.807 (1.091–2.992)), worse DFS (HR 1.788 (1.226–2.607)), and worse OS (HR 1.837 (1.135–2.973)). Other independent risk factors for intra-abdominal recurrence were a R1 resection (HR 2.616 (1.264–5.415)) and N2-stage (HR 2.096 (1.318–3.332)).Conclusion
SSIs after resection of a pT4N0-2M0 colon cancer are associated with an increased risk of intra-abdominal recurrence and worse survival. This finding supports the hypothesis that infection-based immunologic pathways play a role in colon cancer cell dissemination and outgrowth. 相似文献896.
李国治 《临床合理用药杂志》2010,3(14):15-16
目的观察序贯透析对肾功能衰竭合并心力衰竭、肺水肿患者的治疗效果。方法对13例肾功能衰竭合并急性心力衰竭、肺水肿的患者行序贯透析疗法,观察其临床症状、体征,分析其疗效。结果痊愈7例,显效5例,有效1例,总有效率为100.0%。结论序贯透析能迅速缓解肾功能衰竭合并急性左心力衰竭患者的临床症状,改善患者的心功能状况,是抢救肾功能衰竭合并急性左心力衰竭的有效方法 。 相似文献
897.
Scatophagus argus of the family Scatophagidae inflicts painful wounds in fishermen while handling it. The venom induces prominent local tissue damage characterized by pain, edema and necrosis. The pathogenesis of acute muscle damage in gastrocnemius muscle induced by S. argus venom was studied in mice. The inflammatory response induced by S. argus venom in the mice hind paw was studied measuring paw edema. Intramuscular injection of S. argus venom induced motoxicity. The effect of S. argus venom on the cellular components of inflammatory response was investigated. Venom from S. argus were quantitatively analyzed for enzymic and biochemical activity. The biochemical changes induced by the sublethal concentration of S. argus venom and histopathological studies of effect of venom on mice were carried out. Venom induced a rapid increment in serum creatine kinase (CK) and lactate dehydrogenase (LDH) showing the myotoxicity of venom. Concomitant with this a reduction of muscle CK and LDH activity was observed, where as no increment in muscle lactate was detected. Our findings showed that the edematic activity was dose dependent and remained significantly elevated over 48 h after injection. Administration of S. argus venom caused a significant cell accumulation of neutrophils in to peritoneal cavity as well as foot pad up to 24 h with maximal being at 4-6 h. The venom components analyzed showed the presence of phosphodiesterase, acid phosphatases, alkaline phosphatases, proteinase, and caseinolytic activity. SDS PAGE revealed the presence of major and minor protein bands between 6.5 and 68 kDa. The biochemical changes induced by the sublethal concentration of S. argus venom showed reversible changes in the hematological (blood cell count, hematocrit, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin and platelet count) parameters which were significantly altered at 6 and 24 h (GLM repeated measures p < 0.05). Serum enzymes such as AST, ALT, ACP, ALP, LDH and urea were altered significantly which in turn confirmed the damage of vital organ tissue. 相似文献
898.
899.
目的探讨分析胆道术后腹腔引流液中炎性因子检测对胆漏的早期诊断价值。方法将160例胆道术后24h、48h、72h的腹腔引流液分别进行CRP、TNF-α、IL-6的检测,同时对不同原因引起的胆漏患者,进行腹腔引流液检测,对结果进行分析总结。结果 160例胆道手术的患者,术后出现胆漏13例,占8.13%,未出现胆漏147例,占91.87%。13例不同胆漏患者进行术后3次腹腔引流液中炎性因子检测平均结果:CRP(33.76±1.28)mg/L、TNF-α(45.83±2.37)ng/L、IL-6(33.68±4.51)ng/L。胆道患者手术后腹腔引流液中炎性因子均会引起不同程度的升高,而胆漏组患者的腹腔引流液中炎性因子明显高于未出现胆漏的患者。结论胆道术后腹腔引流液炎性因子检测CRP、TNF-α、IL-6早期异常升高,可以作为对早期胆漏的诊断参考依据。 相似文献
900.
目的: 通过检测胃癌腹腔冲洗液中DDC mRNA的表达,探讨多巴胶羟酶(DDC)与胃癌腹膜转移的关系,并为胃癌腹膜转移预测和亚临床转移的筛检提供新的方法。 方法: 用RNA提取和RT-PCR方法检测92例胃癌腹腔冲洗液中DDC mRNA的表达,同时做腹腔冲洗细胞学(PLC)检查;10例良性疾病的腹腔冲洗液作为阴性对照。 结果: 92例胃癌腹腔冲洗液中有57例检测到DDC mRNA的表达(62.0%),其表达阳性率与胃癌腹膜转移的PS因素密切相关(P<0.05);且胃癌腹腔冲洗液中DDC mRNA的表达水平还与胃癌浸润深度、浆膜类型、PLC检查结果以及是否存在肉眼腹膜转移有关,浸润深度深、浆膜受侵程度重、PLC检查结果阳性及存在肉眼腹膜转移病灶者的DDC mRNA表达相对值明显升高(P<0.05);而10例良性疾病腹腔冲洗液均未检测到DDC mRNA的表达。 结论: 胃癌腹腔液中DDC mRNA的表达与胃癌腹膜转移密切相关,通过RT-PCR来检测DDC mRNA适用于胃癌腹膜转移的预测和亚临床转移的筛检。 相似文献